ZYUS Life Sciences Ships Medical Cannabinoid Oil Formulations for Distribution in Australia
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Brucem Mann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Press release content from Business Wire. The AP news staff was not involved in its creation.
The two companies are working together to advance necessary permitting to sell ZYUS’ cannabinoid formulations in the Portuguese marketplace
ZYUS Life Sciences Increases Global Patient Access to Medical Cannabinoids in Australia with Health House International Sales and Distribution Agreement New agreement will enable patients in Australia to access ZYUS’ cannabinoid formulations as part of international expansion SASKATOON, Saskatchewan--(BUSINESS WIRE)--ZYUS Life Sciences Inc. ("ZYUS"), a Canadian life sciences company leading scientific research and development in phyto-therapeutics, is pleased to announce that it has entered a new non-exclusive, multiyear agreement with Australian medical cannabis importer, HHI (Australia) ...